Magic mushroom therapy targets death anxiety in advanced cancer patients
NCT ID NCT06416085
First seen Jan 06, 2026 · Last updated May 21, 2026 · Updated 23 times
Summary
This study tests whether a single high dose of psilocybin (the active ingredient in magic mushrooms), combined with talk therapy, can help people with advanced cancer feel less anxious about death and dying. Fifteen adults with stage IV cancer will receive the treatment and be monitored for safety and emotional benefits. The goal is to see if this approach is practical and acceptable for this group.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ADVANCED CANCER are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Princess Margaret Cancer Centre
Toronto, Ontario, M5G 2M9, Canada
Conditions
Explore the condition pages connected to this study.